M37 Management of Type 1 Diabetes in Athletes

Program: Meet-the-Professor Sessions
Clinical Session
Sunday, April 3, 2016: 10:00 AM-10:45 AM
Room 109 (BCEC)
Sunday, April 3, 2016: 2:15 PM-3:00 PM
Room 109 (BCEC)
Speaker:
Michael C. Riddell, PhD, York University, Toronto, Canada

Disclosures:
MCR: Speaker, Eli Lilly & Company, Speaker, Sanofi, Speaker, Medtronic Minimed.

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire